Table 2. Summary of miRNAs and their targets predicted from in silico analyses based on TCGA database.

MicroRNA	Fold-changea	Predicted target genes
hsa-miR-133a-3p	0.28	AMACR, BCL2, COL1A1, NKX3-1, SIM2
hsa-miR-133b	0.27	AMACR, BCL2, COL1A1, NKX3-1, SIM2
hsa-miR-143-3p	0.40	AMACR, BCL2, COL1A1, GOLM1, MPM11, NKX3-1, OR51E2, SIM2
hsa-miR-183-5p	4.35	AMACR, COL1A1, FOXA1, MPM11, NKX3-1, TRPM8
hsa-miR-200b-3bb	-	AMACR, BCL2, GOLM1, OR51E2, SIM2, TRPM
hsa-miR-200c-3p	3.33	AMACR, BCL2, FOXA1, GOLM1, OR51E2, SIM2, TRPM8
hsa-miR-205-5p	0.36	AMACR, BCL2, COL1A1, GOLM1, MPM11, NKX3-1, SIM2, TRPM8
hsa-miR-375	6.74	AMACR, BCL2, COL1A1, FOXA1, GOLM1, NKX3-1, SIM2, TRPM8

^aFold-change based on The Cancer Genome Atlas (TCGA) data; tumor tissue versus normal tissue.

^bmiRNA selected after investigation in the literature of the candidate miRNAs in prostate cancer